Skip to main content
Clinical Trials/NCT03002701
NCT03002701
Completed
Not Applicable

The Impact of nUrsiNg DEliRium Preventive INterventions in the Intensive Care Unit (UNDERPIN-ICU): A Multi-centre, Stepped Wedge Randomized Controlled Trial

Radboud University Medical Center11 sites in 1 country1,750 target enrollmentDecember 31, 2016
ConditionsDelirium

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Delirium
Sponsor
Radboud University Medical Center
Enrollment
1750
Locations
11
Primary Endpoint
The number of delirium-coma-free days
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Delirium is a common disorder in Intensive Care Unit (ICU) patients and is associated with serious short- and long-term consequences. This study focuses on a program of standardized nursing and physical therapy interventions to prevent delirium in the ICU, and determines the effect of the program on the number of delirium-coma-free days in 28 days and several secondary outcomes in a multicenter randomized controlled trial.

Detailed Description

Delirium is a common disorder in Intensive Care Unit (ICU) patients and is associated with serious short- and long-term consequences, including re-intubations, ICU readmissions, prolonged ICU and hospital stay, persistent cognitive problems, and higher mortality rates. Considering the high incidence of delirium and its consequences, prevention of delirium is imperative. This study focuses on a program of standardized nursing and physical therapy interventions to prevent delirium in the ICU, called UNDERPIN-ICU (nUrsiNg DEliRium Preventive INterventions in the ICU). Objective: To determine the effect of the UNDERPIN-ICU program on the number of delirium-coma-free days in 28 days and several secondary outcomes, such as delirium incidence, the number of days of survival in 28 and 90 days and delirium-related outcomes. Design and Setting: A multicenter stepped wedge cluster randomized controlled trial. Methods: Eight to ten Dutch ICUs will implement the UNDERPIN-ICU program in a randomized order. Every two months the UNDERPIN-ICU program will be implemented in an additional ICU following a two months period of staff training. UNDERPIN-ICU consists of standardized protocols focusing on several modifiable risk factors for delirium, including cognitive impairment, sleep deprivation, immobility and visual and hearing impairment. Participants: ICU patients aged ≥ 18 years (surgical, medical, or trauma) and at high risk for delirium, E-PRE-DELIRIC ≥35%, will be included, unless delirium was detected prior ICU admission, expected length of ICU stay is less then one day or when delirium assessment is not possible.

Registry
clinicaltrials.gov
Start Date
December 31, 2016
End Date
May 31, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • aged ≥ 18 years
  • surgical, medical or trauma patients
  • admitted to one of the participating ICUs
  • at high risk for delirium (\>35% determined with the E-PRE-DELIRIC prediction tool)

Exclusion Criteria

  • delirious before ICU admission
  • an ICU stay \< one day
  • reliable assessment for delirium is not possible due to: sustained coma; serious auditory or visual disorders; inability to understand Dutch; severely mentally disabled; serious receptive aphasia.

Outcomes

Primary Outcomes

The number of delirium-coma-free days

Time Frame: 28 days

The number of days a patient is not delirious and not in coma in 28 days starting from the day of inclusion in the study after ICU admission.

Secondary Outcomes

  • Incidence of physical restraints(28 days)
  • Health related quality of Life (HRQoL)(365 days after ICU admission)
  • ICU length of stay(365 days)
  • Hospital length of stay(365 days)
  • Post-hoc analysis(During admission)
  • Duration of mechanical ventilation(28 days)
  • Incidence of re-intubation(28 days)
  • Incidence of unplanned removal of tubes/catheters(28 days)
  • Delirium incidence(28 days)
  • The number of days of survival(90 days)
  • Incidence of ICU re-admission(28 days)
  • Cost-effectiveness(During ICU admission)

Study Sites (11)

Loading locations...

Similar Trials